Obstructive sleep apnea (OSA) is probably the most common respiratory disorder, with
recent data from the United States and Europe suggesting that between 14% and 49% of …

Obstructive sleep apnoea syndrome (OSAS) is a common clinical condition in which the
throat narrows or collapses repeatedly during sleep, causing obstructive sleep apnoea …

Abstract Study Objectives: The study aimed to document the neurobehavioral outcomes of
patients referred to and treated by a sleep medicine service for moderate to severe …

Obstructive sleep apnoea is a disease of increasing importance because of its
neurocognitive and cardiovascular sequelae. Abnormalities in the anatomy of the pharynx …

Positive airway pressure (PAP) is used to treat obstructive sleep apnea (OSA), central sleep
apnea (CSA), and chronic hypoventilation. This document provides a systematic analysis …

Sleepiness, cognitive performance, and quality of life are overlapping aspects of daytime
function that may be affected in patients with obstructive sleep apnoea/hypopnoea …

Arterial blood pressure rises at apnea termination, and there is increasing evidence that the
sleep apnea–hypopnea syndrome (SAHS) is associated with daytime hypertension but no …

Background The therapeutic and economic benefits of continuous positive airway pressure
(CPAP) for moderate to severe obstructive sleep apnoea (OSA) syndrome have been …

The diagnosis of obstructive sleep apnea syndrome (OSAS) requires the combined
assessment of relevant clinical features and the objective demonstration of abnormal …

Background. Sleep complaints are common in haemodialysis patients. In the general
population, insomnia impacts negatively on health‐related quality of life (HRQoL). The …